Genetic Technologies has expanded its geneType brand of genetic risk assessment tests into the Canadian and New Zealand markets.

The expansion is part of the company's international growth strategy, following its earlier entry into the US market through a partnership with Stayhealthy.

GeneType's Stayhealthy Canada and Stayhealthy New Zealand will oversee GeneType's new market entries, aligning with recent digital transformation achievements and a successful pilot influencer campaign.

The campaign has led to a 500% increase in week-over-week sales. Future developments include additional clinical-grade assessments for new cancers and chronic conditions.